Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation

Gut microbiota and short‐chain fatty acids (SCFAs) are associated with the development of various human diseases. In this study, we examined the role of astragaloside IV in modulating mouse gut microbiota structure and the generation of SCFAs, as well as in slow transit constipation (STC). An STC mo...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiulan, Han, Changpeng, Huang, Liang, Yang, Haojie, Hu, Jiancong, Chen, Huaxian, Dou, Ruoxu, Ren, Donglin, Lin, Hongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417726/
https://www.ncbi.nlm.nih.gov/pubmed/32628809
http://dx.doi.org/10.1111/jcmm.15586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417726/
https://www.ncbi.nlm.nih.gov/pubmed/32628809
http://dx.doi.org/10.1111/jcmm.15586

Ejemplares similares